Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Topical finasteride effectively and safely increases hair growth in men with hair loss.

Ashwagandha serum improves hair health and quality of life in people with hair loss.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

CGF and i-PRF are more effective and safer than PRP for treating female pattern hair loss.

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Platelet-rich plasma, microneedling with minoxidil, and topical finasteride are promising treatments for hair loss.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Ziziphus jujuba Mills may have health benefits, but more research is needed to confirm its safety and effectiveness.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

DA-5512 effectively improves hair growth and health, performing better than minoxidil.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Adding a topical agent to IPL improves hair reduction and satisfaction without extra side effects.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Stem cell therapy shows promise but needs better safety and quality standards.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Activated PRP effectively increases hair density and reduces hair loss in alopecia.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

PDRN helps repair tissue and improve wound healing with a high safety profile.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Platelet-rich plasma is considered safe but needs more research to prove its effectiveness in medical treatments.

Tralokinumab for atopic dermatitis may cause eye issues and skin reactions, needing careful monitoring.

Personalized supplements are important for women's health, but hormone therapy can increase cancer and heart risks.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.